He has a PhD in Pharmaceutical Sciences from the University of Tokyo. He started his career at Astellas Pharma Inc. and then at Arthur D. Little.

Subsequently, after a two-year stint at Deloitti, he joined Terumo Corporation in 2017 in the role of Developed the corporate strategy, Established new business developments.